Skip to main content
. 2022 Feb 4;30(5):1941–1951. doi: 10.1016/j.ymthe.2022.02.001

Table 1.

Luc mRNA-LNP in-use stability at room temperature

Times (h) −80°C frozen Luc mRNA-LNPs
Lyophilized and reconstituted Luc mRNA-LNPs
Z-avg (nm) PDI [mRNA] mg/mL % EE z-avg (nm) PDI [mRNA] mg/mL % EE
0 81 ± 0.6 0.07 ± 0.00 0.53 ± 0.00 97 ± 0.2 99 ± 0.6 0.07 ± 0.02 0.50 ± 0.00 95 ± 2.0
1 81 ± 0.9 0.06 ± 0.02 0.51 ± 0.00 97 ± 0.1 98 ± 0.3 0.07 ± 0.00 0.49 ± 0.00 93 ± 0.2
2 80 ± 0.0 0.09 ± 0.01 0.51 ± 0.01 97 ± 0.1 98 ± 0.3 0.05 ± 0.01 0.49 ± 0.00 93 ± 0.2
4 79 ± 0.3 0.09 ± 0.01 0.51 ± 0.01 97 ± 0.4 96 ± 0.6 0.08 ± 0.01 0.48 ± 0.01 93 ± 0.3
6 79 ± 0.7 0.08 ± 0.02 0.53 ± 0.00 97 ± 0.2 96 ± 0.7 0.07 ± 0.01 0.49 ± 0.01 92 ± 0.0
24 81 ± 0.3 0.08 ± 0.01 0.51 ± 0.00 97 ± 0.1 98 ± 0.3 0.09 ± 0.01 0.50 ± 0.01 92 ± 0.3

Particle size, polydispersity, mRNA concentration, and encapsulation efficiency of frozen and reconstituted lyophilized Luc mRNA-LNPs were measured at room temperature (25°C) at set time points for 24 h. PDI, polydispersity; EE, encapsulation efficiency.